About Us

NucleoBio was borne out of the desire to accomplish the following goals:

  • Fill the gaps and reduce the inaccuracies of Prostate Specific Antigen (PSA) and tests based on PSA that detect benign from aggressive prostate cancer.
  • Provide accurate and less stressful testing methods for men of all ages.
  • Prevent misdiagnoses and watchful waiting through a simple, ground-breaking form of testing.
  • Saving lives and bringing peace of mind.
  • Saving costs by preventing unnecessary treatments, surgeries, and therapies.
  • To conduct medical and scientific research, especially in the field of cancer and men’s health.
  • Pharmaceutical drug development, taking laboratory advances and developing breakthrough cutting-edge therapeutics.

Mission and Vision

We are enduringly committed to providing state-of-the-art prostate screening tests that produce ground-breaking accurate results. We aim to bring a complete method of testing that fills the gaps and diminishes the inconsistencies of PSA and PSA-based tests, saves lives, reduces costs, and brings peace of mind. We want to be known and valued for breaking through the boundaries of men’s health and bringing forth a gold standard in testing for prostate disease.

If you wish to learn more about our organization and our technologies, contact us today.

The Ugly Reality behind Prostate Cancer Screening

  • 1. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends. J National Cancer Institute (2002) 94: 981-990.
  • 2. US Cancer Statistics Working Group, 1999-2013.
  • 3. Trends in prostate cancer in the United States. J National Cancer Institute. (2012): 152.
  • 4. What Is the True Number Needed to Screen and Treat to Save a Life With Prostate-Specific Antigen Testing? J Clinical Oncology (2011) 29: 464-467.
  • 5. Cost-effectiveness of prostate specific antigen screening in the US. J Urology 185(3): 828.
  • 6. Prostac

So What's a Man to Do?


What It Is Prostac


Peace of MindNo misdiagnoses, no watchful waiting

Because of the gaps and inaccuracies of Prostate Specific Antigen (PSA) and tests based on PSA that detect indolent or non-harmful from aggressive Prostate cancer, nearly three-quarters of men will test positive of the disease in their lifetimes.

Men who go through these tests may have to experience painful biopsies that potentially lead to complications. Furthermore, there is the added burden of “watchful waiting” that only heightens their anxiety. A few may even have to go through unnecessary treatments, surgery, or radiation therapy based on the results of their PSA screening test.


AccurateEliminating prostate biopsies

Prostac, our unique and groundbreaking testing method for prostate disease, is a urine-based test that accurately detects the difference between benign and aggressive prostate cancer. There is no need for stress-inducing PSA screening, MRI’s, digital rectal exams, and biopsies. We offer complete peace of mind and the ideal treatment when you require it. In addition, you can expect tests that are specifically designed to bring accurate results for men of all ages.

doctor visiting his patient

Saving Lives

Studies show that in the coming year, approximately 26,730 men in the United States alone will succumb to prostate cancer. However, through a simple, ground-breaking test, such numbers can be greatly reduced and a lot of deaths can be prevented. The current prostate cancer tests are filled with inaccuracies and usually, result in a high rate of misdiagnoses that lead to overtreatment of benign prostate disease. Due to such outcomes, health advocacy groups and physicians have advised patients to avoid getting screened at all. Prostac prevents all these issues by ensuring accurate and factual results each and every time, leading to more lives saved every year.

men jogging

Saving Costs

A staggering amount of 60,000 dollars per patient is spent by hospitals on unnecessary treatment. Furthermore, these treatments tend to lead to a lot of stresses and complications such as erectile dysfunction, urinary incontinence, and more. With a simple, state-of-the-art prostate test such as Prostac, we can greatly reduce or avoid the negative outcomes typical of current PSA screening tests. There would be no need, whatsoever, for radiation therapies, surgeries, and other procedures. Men can focus on their freedom without being subjected to the anxiety-inducing situations of watchful waiting and biopsies.

Want to Learn More?

  • Charles Oyesile, M.D., Ph.D. Co-Founder/C.E.O
  • Olorunseun Ogunwobi, M.D., Ph.D. Co-Founder/Chief Scientific Officer
Valid XHTML 1.0 Transitional
Valid CSS!